Video
Synexa Life Sciences Expands Biomarker Discovery Capabilities with the Addition of Olink® Target Platform
Synexa Life Sciences announces the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive…
04 Mar, 2024 | News